Advertisement
YOU ARE HERE: LAT HomeCollectionsMenopause
IN THE NEWS

Menopause

NEWS
January 24, 2011 | By Karen Kaplan, Los Angeles Times
Among the many harmful substances found in tobacco smoke are some that are thought to cause breast cancer . Among those, researchers have flagged polycyclic aromatic hydrocarbons, aromatic amines and N-nitrosamines. Many studies have investigated the link between smoking and breast cancer, and their conclusions have been mixed. On Monday, a group of Harvard researchers used 30 years worth of data from the long-running Nurses Health Study to conclude that smoking does lead to a modest increase in breast cancer risk, but only in premenopausal women.
Advertisement
NEWS
December 17, 2010 | By Mary Forgione, For the Los Angeles Times
Tired of documentaries about global warming? Here’s a film that covers a personal warming topic: hot flashes. This Health Notes blog of the Newport News Daily Press talks about the film "Hot Flashes Havoc. " The documentary, in part, says: "By the year 2015 the number of menopausal women worldwide is expected to reach approximately 1.7 billion. " But this film isn't just about numbers. It examines whether hormonal replacement therapy increases the risk of heart attacks and cancer (this film thinks not)
HEALTH
December 10, 2010 | By Shari Roan, Los Angeles Times
A class of drugs that has been increasingly used to treat breast cancer in recent years may not improve survival rates in younger women with the disease, researchers reported Thursday. The medications ? bone-building drugs called bisphosphonates ? have generated enthusiasm among cancer researchers because of their potential to slow the growth of cancer cells in bone and improve bone strength. But a large study on a potent bisphosphonate called zoledronic acid, or Zometa, found that the drug did not improve survival for patients with early stage breast cancer except among a subset of women who were five or more years past menopause.
HEALTH
September 6, 2010 | By Valerie Ulene, Special to the Los Angeles Times
I'm 46, and there are days when it feels like I'm completely losing my mind. I misplace my car keys, struggle to remember details of recent conversations, and can't recall seemingly anybody's name. To help cope with my mental cloudiness, I always keep an extra set of keys nearby, write endless sticky notes to myself, and frequently opt for the generic "hello" over more personalized greetings. Strategies like these may help me get through my day, but they fail to calm the nagging concern that something is seriously wrong with me. They also do nothing to combat the other "symptoms" that have developed over the last year or two, namely trouble sleeping and a vague sense of doom and gloom.
NEWS
July 29, 2010
The Food and Drug Administration on Thursday warned menopausal women using Evamist to avoid allowing children and pets to come into contact with the drug. Evamist contains the estrogen hormone estradiol and is sprayed on the forearms between the elbow and wrist to reduce hot flashes. The FDA said it has received eight reports of adverse effects from exposure to the drug in children ages 3 to 5, and two reports of problems with pets. Young girls who came into contact with the drug reported symptoms of premature puberty, including development of breast buds and breast mass.
HEALTH
June 7, 2010 | By Chris Woolston, Special to the Los Angeles Times
When a woman stops making estrogen, her body notices. Hot flashes, night sweats, moodiness, foggy thinking — all can be part of the menopausal package. At first blush, the solution seems obvious: Take extra hormones, and the symptoms of menopause should vanish. Over the decades, millions of women have taken some form of hormone therapy to relieve symptoms of menopause or to prevent the bone-thinning disease osteoporosis. The treatment typically included Premarin, estrogen isolated from the urine of pregnant mares, combined with Provera, a synthetic version of the hormone progesterone.
HEALTH
February 16, 2009 | Karen Kaplan
The news about vitamins keeps getting worse. A spate of high-profile studies published in the last few years shows that a variety of popular supplements -- including calcium, selenium and vitamins A, C and E -- don't do anything to reduce the risk of developing heart disease, stroke or a variety of cancers. But what about multivitamins? These combination pills, which contain 10 to 30 vitamins and minerals, are the most popular dietary supplements sold in America.
NATIONAL
December 14, 2008 | Associated Press
Taking menopause hormones for five years doubles the risk for breast cancer, according to a new analysis of a big federal study that reveals the most dramatic evidence yet of the dangers of these popular pills. Even women who took estrogen and progestin pills for just a couple of years had a greater chance of getting cancer. But when they stopped, their odds quickly improved, returning to a normal risk level about two years later.
HEALTH
February 11, 2008 | Janet Cromley, Times Staff Writer
Thanks to Viagra, Cialis and Levitra, men with erectile dysfunction can get on board the Food and Drug Administration-approved love train. But women who experience a different sexual problem -- sagging libido -- have been left at the station. That may be changing. BioSante Pharmaceuticals Inc. is testing the safety and effectiveness of LibiGel, a testosterone gel for women designed to combat declines in sexual arousal associated with menopause. There are currently no drugs available in the U.S.
HEALTH
July 30, 2007
Since, according to your July 23 article by Shari Roan ["Hormones: Is Age the Key?"] I qualify as a member of the group of women who should not take hormones, I could not help but be annoyed, once again. These "studies" are reminiscent of the caffeine studies whereby every few years there are a different set of standards and results. My mother did not take replacement hormones and had a silent heart attack and Alzheimer's.
Los Angeles Times Articles
|